🔎 Trials Near Me

Akèy › Kansè pwostat › Missouri

Etid klinik pou Kansè pwostat nan Missouri

47 etid pou Kansè pwostat ap chèche patisipan nan sit nan Missouri.

Vil nan Missouri

Tèks ofisyèl etid la (Anglè)

Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

  • Saint Francis Medical Center, Cape Girardeau
  • Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters
  • Siteman Cancer Center at West County Hospital, Creve Coeur
  • ak 10 plis
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Oct 2, 2026 · NCT06931340

Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

  • Heartland Regional Medical Center, Saint Joseph
  • Missouri Baptist Medical Center, St Louis
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Oct 2, 2026 · NCT07200830

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

  • Washington University School of Medicine in St. Louis, St Louis
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT06465069

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Mercy Oncology and Hematology - Clayton-Clarkson, Ballwin
  • Central Care Cancer Center - Bolivar, Bolivar
  • Cox Cancer Center Branson, Branson
  • ak 21 plis
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 40 a 75 · Tout sèks · Mizajou Oct 2, 2026 · NCT05334069

Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

  • Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters
  • Siteman Cancer Center at West County Hospital, Creve Coeur
  • Washington University School of Medicine, St Louis
  • ak 2 plis
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT06632977

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

  • Washington University, School of Medicine, St Louis
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06172478

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

  • Saint Francis Medical Center, Cape Girardeau
  • Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters
  • Siteman Cancer Center at West County Hospital, Creve Coeur
  • ak 11 plis
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT03866382

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

  • Washington University, St Louis
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07114601

Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

  • Wash U School of Medicine, St Louis
Ap rekriteFaz 3
Laj 18 a 100 · Gason · Mizajou Sep 22, 2026 · NCT06855277

High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers

  • Kansas City VA Medical Center, Kansas City, MO, Kansas City
  • St. Louis VA Medical Center John Cochran Division, St. Louis, MO, St Louis
Ap rekriteFaz 2
Laj 18 ak plis · Gason · Mizajou Sep 17, 2026 · NCT05011383

Carboplatin or Olaparib for BRcA Deficient Prostate Cancer

  • Kansas City VA Medical Center, Kansas City, MO, Kansas City
Ap rekriteFaz 2
Laj 18 ak plis · Gason · Mizajou Sep 17, 2026 · NCT04038502

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

  • Saint Francis Medical Center, Cape Girardeau
  • Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters
  • Siteman Cancer Center at West County Hospital, Creve Coeur
  • ak 10 plis
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Sep 10, 2026 · NCT05946213

Daily Adaptive Radiation Therapy Using an Individualized Approach for Prostate Cancer

  • Washington University in St. Louis, St Louis
Ap rekrite
Laj 18 ak plis · Gason · Mizajou Sep 9, 2026 · NCT05804318

A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

  • Washington University School of Medicine, St Louis
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT06440005

Study of JANX014 in Subjects With Metastatic Castration-Resistant Prostate Cancer

  • Washington University School of Medicine, St Louis
Ap rekriteFaz 1
Laj 18 ak plis · Gason · Mizajou Sep 3, 2026 · NCT07545811

The Vanguard Study: Testing a New Way to Screen for Cancer

  • Saint Luke's Hospital of Kansas City, Kansas City
  • Washington University School of Medicine, St Louis
Ap rekriteVolontè an sante akeyi
Laj 45 a 75 · Tout sèks · Mizajou Sep 2, 2026 · NCT06995898

AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)

  • Research Site, St Louis
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Aug 26, 2026 · NCT07611110

A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss

  • St. Louis VA Medical Center John Cochran Division, St. Louis, MO, St Louis
Ap rekriteFaz 2
Laj 18 ak plis · Gason · Mizajou Aug 25, 2026 · NCT05593497

Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer

  • Washington University, St Louis
Ap rekriteFaz 1
Laj 18 ak plis · Gason · Mizajou Aug 21, 2026 · NCT04221542

A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC

  • Siteman Cancer Center, St Louis
Ap rekriteFaz 1/2
Laj 18 ak plis · Gason · Mizajou Aug 20, 2026 · NCT06785636

Impact of an Electronic Health Record Maintenance Alert on PSA Screening Rates in a 10-Hospital Integrated Health System

  • Washington University School of Medicine, St Louis
Ap rekriteVolontè an sante akeyi
Laj 40 a 75 · Gason · Mizajou Aug 19, 2026 · NCT07109427

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

  • Central Care Cancer Center - Bolivar, Bolivar
  • Mercy Cancer Center - Cape Girardeau, Cape Girardeau
  • Saint Francis Medical Center, Cape Girardeau
  • ak 19 plis
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Aug 19, 2026 · NCT04423211

FOG-001 in Locally Advanced or Metastatic Solid Tumors

  • Washington University School of Medicine, St Louis
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Aug 17, 2026 · NCT05919264

Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)

  • Washington University School of Medicine, St Louis
Ap rekriteFaz 1
Laj 18 a 100 · Gason · Mizajou Aug 13, 2026 · NCT05519449

IDOV-Immune for Advanced Solid Tumors

  • Washington University School of Medicine, St Louis
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Aug 5, 2026 · NCT06910657

Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer

  • Washington University, St Louis
Ap rekriteFaz 1
Laj 18 ak plis · Gason · Mizajou Jul 31, 2026 · NCT06613100

Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors

  • Investigative Site #110, St Louis
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Jul 23, 2026 · NCT06545942

PSMA PET Combined With MRI for the Detection of PCa

  • Washington University, St Louis
Ap rekriteFaz 3Volontè an sante akeyi
Laj 18 ak plis · Gason · Mizajou Jul 23, 2026 · NCT07052214

Low-Count Quantitative SPECT for Men Treated With Radium-223

  • Washington University School of Medicine, St Louis
Ap rekrite
Laj 18 ak plis · Gason · Mizajou Jul 21, 2026 · NCT07221825

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

  • Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters
  • Siteman Cancer Center at West County Hospital, Creve Coeur
  • Washington University School of Medicine, St Louis
  • ak 2 plis
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Jul 14, 2026 · NCT06592924

Diffusion Basis Spectrum Imaging of the Prostate

  • Washington University School of Medicine, St Louis
Ap rekrite
Laj 18 ak plis · Gason · Mizajou Jul 14, 2026 · NCT04420702

CARE Tool Study Aim 3

  • Delbert Day Cancer Institute at Phelps Health, Rolla
  • Washington University School of Medicine, St Louis
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jul 8, 2026 · NCT07296887

Integrated Cancer Repository for Cancer Research

  • Saint Luke's Cancer Institute, East, Kansas City
  • Saint Luke's Cancer Institute, Kansas City
  • Saint Luke's Cancer Institute, Kansas City North, Kansas City
  • ak 3 plis
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 19 a 110 · Tout sèks · Mizajou Jun 29, 2026 · NCT02012699

Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy

  • Mercy David C. Pratt Cancer Center, St Louis
Ap rekrite
Laj 18 ak plis · Gason · Mizajou Jun 17, 2026 · NCT00969111

Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.

  • VA St. Louis Health Care System, St Louis
Ap rekriteFaz 2
Laj 18 ak plis · Gason · Mizajou Jun 15, 2026 · NCT05422911

Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy

  • Alvin J. Siteman Cancer Center at Washington University, St Louis
Ap rekriteFaz 2
Laj 18 ak plis · Gason · Mizajou Jun 4, 2026 · NCT03821246

Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer

  • Wash U School of Medicine, St Louis
Ap rekriteFaz 4
Laj 18 a 100 · Gason · Mizajou Jun 4, 2026 · NCT05803941

Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate Treatment

  • Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters
  • Siteman Cancer Center at West County Hospital, Creve Coeur
  • Washington University School of Medicine, St Louis
  • ak 2 plis
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Apr 14, 2026 · NCT06235697

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.